MIYUKI INOUE-MOCHITA

イノウエーモチタミユキ | MIYUKI INOUE-MOCHITA

Research field (1)： Molecular biology

Research theme for competitive and other funds (4)：

2021 - 2024 緑内障術後創傷治癒におけるエピゲノム変化とメモリー効果に関する研究
2015 - 2018 Investigation of glaucoma pathogenesis based on molecular signalings of TGF-beta and IL-6-medicated trans-signaling
2013 - 2015 Investigation of regulatory mechanisms of aqueous outflow based on molecular signalings of TGF-beta and proinflammatory cytokines.
2008 - 2010 The study for cell-cell interaction and molecular signals about maintenance of retina stem cell

Papers (35)：

浦橋舞衣, 藤本智和, 井上みゆき, 井上俊洋. シュレム管内皮細胞に対するIL-6トランスシグナル経路の影響. 日本緑内障学会抄録集. 2023. 34回. 208-208
Tomokazu Fujimoto, Miyuki Inoue-Mochita, Toshihiro Inoue. A ROCK inhibitor suppresses the transforming growth factor-beta-2-induced endothelial-mesenchymal transition in Schlemm's canal endothelial cells. Scientific reports. 2023. 13. 1. 9655-9655
藤本智和, 井上みゆき, 井上俊洋. シュレム管内皮細胞においてp38阻害剤はTGF-beta2誘発EndMT様変化を抑制する. 日本眼科学会雑誌. 2023. 127. 臨増. 191-191
Kenichi Nakamura, Sachi Kojima, Miyuki Inoue-Mochita, Hidenobu Tanihara, Toshihiro Inoue. Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma. Experimental eye research. 2022. 223. 109204-109204
藤本智和, 井上みゆき, 井上俊洋. シュレム管内皮細胞におけるTGF-β2誘発EndMT様変化に対するROCK阻害剤の影響. 日本眼科学会雑誌. 2022. 126. 臨増. 250-250

ｍore...

MISC (21)：

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page